Skip to content
Clinical Trials – home

PENTETIC ACID: A Comprehensive Guide for Patients

1 / 1
trials open to patients / all trials
1+
Countries

In short

Pentetic acid, also known as DTPA (diethylenetriaminepentaacetic acid), is being studied in clinical trials for its potential to remove gadolinium from the body and treat various conditions. This article explores the ongoing research on pentetic acid, its applications in gadolinium deposition disease, and other potential uses in medical treatments.

At a glance

Main Uses in Trials
Gadolinium removal, treatment of gadolinium deposition disease, assessment of kidney function
Administration Method
Intravenous infusion, often as Ca-DTPA and Zn-DTPA on alternating days
Treatment Duration
Varies by study, ranging from a few infusions to 40-50 infusions over a year
Potential Benefits
Gadolinium removal, symptom reduction in GDD, improved quality of life
Monitored Outcomes
Gadolinium levels in urine, pain scores, cognitive function, quality of life measures
Safety Considerations
Monitoring for renal function changes, hypocalcemia, hypoglycemia
Other Applications
Potential use in peripheral artery disease, critical limb ischemia

What is Pentetic Acid?

Pentetic acid, also known as DTPA (Diethylenetriaminepentaacetic acid), is a medication used primarily for removing certain harmful metals from the body. It belongs to a class of drugs called chelating agents. Pentetic acid comes in two main forms: Calcium DTPA (Ca-DTPA) and Zinc DTPA (Zn-DTPA).

Other names for pentetic acid include: Calcium DTPA (Ca-DTPA) Zinc DTPA (Zn-DTPA) Diethylenetriaminepenta-acetate

Uses of Pentetic Acid

Pentetic acid is primarily used for the following purposes:

  1. Removing heavy metals: It is approved by the U.S. Food and Drug Administration (FDA) for removing certain radioactive heavy metals from the body.
  2. Treating Gadolinium Deposition Disease (GDD): Pentetic acid is being studied for treating patients who have retained gadolinium (a contrast agent used in MRI scans) in their bodies and developed symptoms after the scan.
  3. Measuring kidney function: Some forms of pentetic acid are being investigated as a way to measure glomerular filtration rate (GFR), which is an indicator of kidney function.

How Pentetic Acid Works

Pentetic acid works as a chelating agent. This means it can bind to certain metals in the body, forming a stable compound that can be excreted through urine. This process helps remove harmful metals from the body.

In the case of Gadolinium Deposition Disease, pentetic acid is thought to bind to gadolinium that has been retained in the body after an MRI scan, allowing it to be eliminated through urine.

Administration and Dosage

Pentetic acid is typically administered intravenously (through a vein). The exact dosage and administration schedule can vary depending on the specific condition being treated and the form of pentetic acid being used. Here's an example of how it might be given:

  • For Gadolinium Deposition Disease: Patients may receive 2.5 mL (500 mg) of Ca-DTPA over one minute, followed by a saline infusion. This process is then repeated with Zn-DTPA the following day. The two-day procedure may be repeated multiple times over several weeks.

It's important to note that the dosage and administration should always be determined by a healthcare professional based on the individual patient's needs and condition.

Potential Side Effects

While pentetic acid has been used for over 60 years and is generally well-tolerated, like all medications, it can have side effects. Some potential side effects may include:

  • Changes in mineral levels in the body
  • Kidney function changes
  • Nausea or vomiting
  • Headache
  • Dizziness

However, it's important to note that not everyone experiences side effects, and your doctor will monitor you closely during treatment.

Ongoing Research

Pentetic acid is currently being studied for various uses:

  • Gadolinium Deposition Disease: Researchers are investigating whether pentetic acid can help reduce symptoms in patients who have retained gadolinium after MRI scans.
  • Kidney Function Measurement: Some forms of pentetic acid are being studied as a potential way to measure kidney function more accurately.
  • Cancer Treatment: There is ongoing research to determine if pentetic acid could help improve the effectiveness of chemotherapy in certain types of leukemia by reducing metal levels in the bone marrow and blood.

It's important to note that while these studies show promise, more research is needed to fully understand the potential benefits and risks of using pentetic acid for these purposes.

Questions people often ask

Conditions where Pentetic Acid is being studied

Each condition opens its own overview and trial list

Trials with Pentetic Acid

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).